MedPath

Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation

Not Applicable
Completed
Conditions
Lip Augmentation and Correction of Perioral Rhytids
Registration Number
NCT02703948
Lead Sponsor
Galderma R&D
Brief Summary

This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subjects willing to comply with the requirements of the study and providing written informed consent including release of copyright of photography images.
  • Males or females, 22 years of age or older
  • Subjects seeking augmentation therapy for the lips.
Exclusion Criteria
  • History of allergy or hypersensitivity to injectable HA gel or to gram positive bacterial proteins.
  • History of allergy or hypersensitivity to lidocaine, other amide type anesthetics, or topical anesthetics or nerve blocking agents
  • Previous surgery to the upper or lower lip, lip piercing or tattoo, or history of facial trauma.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

United States, California

🇺🇸

San Diego, California, United States

United States, Florida

🇺🇸

Miami, Florida, United States

United States, Georgia

🇺🇸

Roswell, Georgia, United States

United States, California
🇺🇸San Diego, California, United States
© Copyright 2025. All Rights Reserved by MedPath